Sophia Genetics
Standardizes clinical genomic data using AI to support precision oncology worldwide.
What they do
Sophia Genetics offers a cloud-based platform that analyzes genomic and clinical data. Hospitals, laboratories, and research institutions worldwide license this software to interpret complex genetic sequencing, facilitating more precise diagnoses and targeted treatment decisions for cancer and other rare genetic disorders.
The record
- Vertical
- Oncology
- Sub-segment
- Precision medicine platform
- Product type
- Platform software
- Stage
- Public
- Headquarters
- Saint-Sulpice, Switzerland
- Region
- Europe
- Founded
- 2011
- Total funding
- $250M raised
Notable investors: Generation Investment Management, Idinvest Partners, Balderton Capital, Alychlo.